The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Overdiagnosis of Clostridium difficile Infection in the Molecular Test Era
Open accessAbstract
IMPORTANCE: Clostridium difficile is a major cause of health care-associated infection, but disagreement between diagnostic tests is an ongoing barrier to clinical decision making and public health reporting. Molecular tests are increasingly used to diagnose C difficile infection (CDI), but many molecular test-positive patients lack toxins that historically defined disease, making it unclear if they need treatment. OBJECTIVE: To determine the natural history and need for treatment of patients who are toxin immunoassay negative and polymerase chain reaction (PCR) positive (Tox-/PCR+) for CDI. DESIGN, SETTING, AND PARTICIPANTS: Prospective observational cohort study at a single academic medical center among 1416 hospitalized adults tested for C difficile toxins 72 hours or longer after admission between December 1, 2010, and October 20, 2012. The analysis was conducted in stages with revisions from April 27, 2013, to January 13, 2015. MAIN OUTCOMES AND MEASURES: Patients undergoing C difficile testing were grouped by US Food and Drug Administration-approved toxin and PCR tests as Tox+/PCR+, Tox-/PCR+, or Tox-/PCR-. Toxin results were reported clinically. Polymerase chain reaction results were not reported. The main study outcomes were duration of diarrhea during up to 14 days of treatment, rate of CDI-related complications (ie, colectomy, megacolon, or intensive care unit care) and CDI-related death within 30 days. RESULTS: Twenty-one percent (293 of 1416) of hospitalized adults tested for C difficile were positive by PCR, but 44.7% (131 of 293) had toxins detected by the clinical toxin test. At baseline, Tox-/PCR+ patients had lower C difficile bacterial load and less antibiotic exposure, fecal inflammation, and diarrhea than Tox+/PCR+ patients (P < .001 for all). The median duration of diarrhea was shorter in Tox-/PCR+ patients (2 days; interquartile range, 1-4 days) than in Tox+/PCR+ patients (3 days; interquartile range, 1-6 days) (P = .003) and was similar to that in Tox-/PCR- patients (2 days; interquartile range, 1-3 days), despite minimal empirical treatment of Tox-/PCR+ patients. No CDI-related complications occurred in Tox-/PCR+ patients vs 10 complications in Tox+/PCR+ patients (0% vs 7.6%, P < .001). One Tox-/PCR+ patient had recurrent CDI as a contributing factor to death within 30 days vs 11 CDI-related deaths in Tox+/PCR+ patients (0.6% vs 8.4%, P = .001). CONCLUSIONS AND RELEVANCE: Among hospitalized adults with suspected CDI, virtually all CDI-related complications and deaths occurred in patients with positive toxin immunoassay test results. Patients with a positive molecular test result and a negative toxin immunoassay test result had outcomes that were comparable to patients without C difficile by either method. Exclusive reliance on molecular tests for CDI diagnosis without tests for toxins or host response is likely to result in overdiagnosis, overtreatment, and increased health care costs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multistate point-prevalence survey of health care-associated infections
Magill, S. S., Edwards, J. R., Bamberg, W., Beldavs, Z. G., Dumyati, G., Kainer, M. A., Lynfield, R., Maloney, M., McAllister-Hollod, L., Nadle, J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306801 · Cited by 3,931
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
McDonald, L. C., Killgore, G. E., Thompson, A., Owens, R. C., Kazakova, S. V., Sambol, S. P., Johnson, S., & Gerding, D. N. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051590 · Cited by 2,006
Clostridium difficile infection: new developments in epidemiology and pathogenesis
Rupnik, M., Wilcox, M. H., & Gerding, D. N. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2164 · Cited by 1,380 · cited 5×
“Duration of metronidazole or oral vancomycin, if treated, median (IQR), d 14 (11-14) 6 (3-11) 5 (2-9) <.”
BackgroundInfluentialPepin, J. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1041104 · Cited by 1,128
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
Clostridium Difficile-Associated Diarrhea and Colitis
Gerding, D. N., Johnson, S., Peterson, L. R., Mulligan, M. E., & Silva, J. (1995) · Infection Control & Hospital Epidemiology · doi:10.1086/648363 · Cited by 631
Burden of Clostridium difficile on the Healthcare System
Dubberke, E. R., & Olsen, M. A. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis335 · Cited by 557
Clinical Recognition and Diagnosis of Clostridium difficile Infection
Bartlett, J. G., & Gerding, D. N. (2008) · Clinical Infectious Diseases · doi:10.1086/521863 · Cited by 527
Planche, T. D., Davies, K. A., Coen, P. G., Finney, J. M., Monahan, I. M., Morris, K. A., O'Connor, L., Oakley, S. J., Pope, C. F., Wren, M. W., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70200-7 · Cited by 435
Carey-Ann, B. D., & Carroll, K. C. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-13 · Cited by 423
Gerding, D. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360130117016 · Cited by 370
Zilberberg, M. D., Shorr, A. F., & Kollef, M. H. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1406.071447 · Cited by 362
Davies, K. A., Longshaw, C. M., Davis, G. L., Bouza, E., Barbut, F., Barna, Z., Delmée, M., Fitzpatrick, F., Ivanova, K., Kuijper, E., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70991-0 · Cited by 343
Clostridium difficile Colonization and Diarrhea at a Tertiary Care Hospital
Samore, M. H., DeGirolami, P. C., Tlucko, A., Lichtenberg, D. A., Melvin, Z. A., & Karchmer, A. W. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.181 · Cited by 251
Longtin, Y., Trottier, S., Brochu, G., Paquet-Bolduc, B., Garenc, C., Loungnarath, V., Beaulieu, C., Goulet, D., & Longtin, J. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis840 · Cited by 224
Walker, A. S., Eyre, D. W., Wyllie, D. H., Dingle, K. E., Griffiths, D., Shine, B., Oakley, S., O'Connor, L., Finney, J., Vaughan, A., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit127 · Cited by 214
Vital Signs: Preventing Clostridium difficile Infections
(2012) · JAMA · doi:10.1001/jama.307.16.1684 · Cited by 209
Serum Antibody Response to Toxins A and B of Clostridium difficile
Viscidi, R., Laughon, B. E., Yolken, R., Bo-Linn, P., Moench, T., Ryder, R. W., & Bartlett, J. G. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.1.93 · Cited by 204
Dubberke, E. R., Han, Z., Bobo, L., Hink, T., Lawrence, B., Copper, S., Hoppe-Bauer, J., Burnham, C.-A. D., & Dunne, W. M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00891-11 · Cited by 186
Nosocomial Diarrhea: Evaluation and Treatment of Causes Other Than Clostridium difficile
Polage, C. R., Solnick, J. V., & Cohen, S. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis551 · Cited by 183
Self-citationClinical and laboratory observations in Clostridium difficile colitis
Bartlett, J. G., Taylor, N. S., Chang, T., & Dzink, J. (1980) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/33.11.2521 · Cited by 162
Prevalence and Risk Factors for Asymptomatic Clostridium difficile Carriage
Alasmari, F. A., Seiler, S. M., Hink, T., Burnham, C. D., & Dubberke, E. R. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu258 · Cited by 152
Humphries, R. M., Uslan, D. Z., & Rubin, Z. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.02970-12 · Cited by 128
Gould, C. V., Edwards, J. R., Cohen, J., Bamberg, W., Clark, L. A., Farley, M. M., Johnston, H. L., Nadle, J., Winston, L. G., Gerding, D. N., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit492 · Cited by 107
Wilcox, M. H., Planche, T., Fang, F. C., & Gilligan, P. H. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02028-10 · Cited by 105
An Epidemic, Toxin Gene–Variant Strain of Clostridium difficile
Snydman, D. R. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70386-9 · Cited by 102
Koo, H. L., Van, J. N., Zhao, M., Ye, X., Revell, P. A., Jiang, Z., Grimes, C. Z., Koo, D. C., Lasco, T. M., Kozinetz, C. A., et al. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/676433 · Cited by 101
Leekha, S., Aronhalt, K. C., Sloan, L. M., Patel, R., & Orenstein, R. (2013) · American Journal of Infection Control · doi:10.1016/j.ajic.2012.09.023 · Cited by 93
Laboratory Diagnosis of Clostridium difficile Infections: There Is Light at the End of the Colon
Brecher, S. M., Novak-Weekley, S. M., & Nagy, E. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit424 · Cited by 82
Clostridium Difficile Infections (CDI) in Hospital Stays, 2009
Lucado, J. L., Gould, C., & Elixhauser, A. (2012) · Cited by 79
Gerding, D. N. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.1.95 · Cited by 71
Moehring, R. W., Lofgren, E., & Anderson, D. J. (2013) · Infection Control and Hospital Epidemiology · doi:10.1086/673144 · Cited by 70
Kaltsas, A., Simon, M., Unruh, L. H., Son, C. H., Wroblewski, D., Musser, K. A., Sepkowitz, K. A., Babady, N. E., & Kamboj, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.05711-11 · Cited by 67
Clinical and laboratory evaluation of a real-time PCR for Clostridium difficile toxin A and B genes
de Jong, E., de Jong, A. S., Bartels, C. J. M., den Biggelaar, C. V. D. R.-V., Melchers, W. J. G., & Sturm, P. (2012) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-012-1558-1 · Cited by 64
Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection
Baker, I., Leeming, J. P., Reynolds, R., Ibrahim, I., & Darley, E. S. R. (2013) · Journal of Hospital Infection · doi:10.1016/j.jhin.2013.05.006 · Cited by 54
Outcomes in patients tested for Clostridium difficile toxins
Polage, C. R., Chin, D. L., Leslie, J. L., Tang, J., Cohen, S. H., & Solnick, J. V. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.08.019 · Cited by 48
Self-citationEvaluation of Repeat Clostridium difficile Enzyme Immunoassay Testing
Cardona, D. M., & Rand, K. H. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00931-08 · Cited by 46
Berry, N., Sewell, B., Jafri, S., Puli, C., Vagia, S., Lewis, A. M., Davies, D., Rees, E., & Ch’ng, C. L. (2014) · Journal of Hospital Infection · doi:10.1016/j.jhin.2014.03.005 · Cited by 45
Clostridium difficile culture-positive toxin-negative diarrhea.
Lashner, B. A., Todorczuk, J. R., Sahm, D. F., & Hanauer, S. B. (1986) · PubMed · Cited by 42
Khanna, S., Pardi, D. S., Rosenblatt, J. E., Patel, R., Kammer, P. P., & Baddour, L. M. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3182432273 · Cited by 36
Huang, B., Jin, D., Zhang, J., Sun, J. Y., Wang, X., Stiles, J., Xu, X., Kamboj, M., Babady, N. E., & Tang, Y. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02601-13 · Cited by 36
Self-citationBorek, A. P., Aird, D. Z., & Carroll, K. C. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.6.2994-2995.2005 · Cited by 30
Cited by
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
Changes in prevalence of health care-associated infections in U.S. hospitals
Magill, S. S., O’Leary, E., Janelle, S. J., Thompson, D. L., Dumyati, G., Nadle, J., Wilson, L. E., Kainer, M. A., Lynfield, R., Greissman, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801550 · Cited by 1,249
Liu, J., Platts-Mills, J. A., Juma, J., Kabir, F., Nkeze, J., Okoi, C., Operario, D. J., Uddin, J., Ahmed, S., Alonso, P. L., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31529-x · Cited by 865
Clostridium difficile infection
Smits, W. K., Lyras, D., Lacy, D. B., Wilcox, M. H., & Kuijper, E. J. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.20 · Cited by 853
Kelly, C. R., Khoruts, A., Staley, C., Sadowsky, M. J., Abd, M., Alani, M., Bakow, B., Curran, P., McKenney, J., Tisch, A., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m16-0271 · Cited by 613
Metadata
- Authors
- Polage, C. R., Gyorke, C. E., Kennedy, M. A., Leslie, J. L., Chin, D. L., Wang, S., Nguyen, H. H., Huang, B., Tang, Y.-W., Lee, L. W., Kim, K., Taylor, S., Romano, P. S., Panacek, E. A., Goodell, P. B., Solnick, J. V., & Cohen, S. H.
- Venue
- JAMA Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2015-11-01
- Volume
- 175
- Issue
- 11
- Pages
- 1792
- ISSN
- 2168-6106 (ISSN-L)
- OpenAlex
- W2167805911
- Cited by
- 593
- References
- 42
- FWCI
- 49.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.